NyquistAI released three new FDA guidances this month.
Public source
Publisher name
Public post
I guess the only thing that will not change in #regulatory #intelligence is that change always happen. This month #FDA released three new guidances. Check out our free G…
Company
NyquistAI
One AI platform for the world’s data, insight, and market intelligence to power life sciences innovation
- Industry
- Software Development
- Location
- Palo Alto, US
- Company size
- 11–50 employees
About NyquistAI
NyquistAI is the one AI life sciences platform for global data, insight and intelligence. Based in the heart of Silicon Valley and graduated from the prestigious Google Accelerator, NyquistAI aggregates and synthesizes planet-scale data to enable you to distill and digest decades of information in seconds to discover insights you didn’t and couldn’t know existed and uncover opportunities that were previously out of reach. The clarity and speed provided by having only the most relevant, accurate, and most up-to-date information and knowledge at your fingertips empower transformative decision-making that accelerates your speed to market. We are trusted by CXOs of the top 50 pharma, Medtech, and CROs such as Medtronic, Astellas, and NAMSA. Visit us at www.nyquistai.com to book a demo to learn how the latest AI technology and transform your innovation today and into the future.
See moreLatest activity
Latest activity from NyquistAI
3 signals
Technology & Infrastructure
NyquistAI developed an AI agent that monitors FDA and automatically provides a granular comparison of new and previous versions of regulatory guidances.
Legal & Regulatory
NyquistAI announced that the FDA released three new regulatory guidances released more than 20 years ago.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Qoolo
Qoolo published a Medical Micro-Content White Paper exploring how micro-content can support more relevant scientific engagement in life sciences.
Research & Knowledge
MasterControl
MasterControl co-authored BioPhorum's new paper titled Artificial Intelligence Risk Guidance for the Pharmaceutical Industry: Harmonizing Frameworks for Practical Implementation.
Research & Knowledge
AlphaLife Sciences
AlphaLife Sciences published AuroraPrime RMA 2026.08.30 focusing on handoffs in regulatory affairs, including finding information in associated documents, working with TFLs in a CSR, reusing approved TFLs for a Lay Summary, and expanding a CMC project.
Research & Knowledge
IntellaQuest
IntellaQuest published a blog post examining ALCOA principles, their importance, and how they help maintain reliable and trustworthy records in a modern QMS.
Research & Knowledge
Axtria - Ingenious Insights